Skip to main content
Log in

S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen

Kapitel „Insomnie bei Erwachsenen“ (AWMF-Registernummer 063-003), Update 2016

S3 Guidelines on non-restorative sleep/sleep disorders

Chapter “Insomnia in adults” – update 2016

  • Leitlinie
  • Published:
Somnologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. A.1

Notes

  1. http://www.content-info.org/public/berichtsband/CONTENT_Berichtsband_1.pdf

Literatur

1.1. Leitlinienreport

  1. Mayer G, Fietze I, Fischer J, Penzel T, Riemann D, Rodenbeck A, Sitter H, Teschler H (2009) S3-Leitlinie Nicht-erholsamer Schlaf/Schlafstörungen. Somnologie (Berl) 13:1–160

    Google Scholar 

2.1. Ätiologie und Pathophysiologie

  1. Baglioni C, Spiegelhalder K, Lombardo C, Riemann D (2010) Sleep and emotions: a focus on insomnia. Sleep Med Rev 14:227–238

    Article  PubMed  Google Scholar 

  2. Bonnet MH, Arand DL (2010) Hyperarousal and insomnia: state of the science. Sleep Med Rev 14:9–15

    Article  PubMed  Google Scholar 

  3. Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin (2006). Leitlinie Schicht- und Nachtarbeit. http://www.asu-arbeitsmedizin.com/ASU-2006-8/Arbeitsmedizinische-Leitlinie-der-Deutschen-Gesellschaft-fuer-Arbeitsmedizin-und-Umweltmedizin-e-V-BRNacht-und-Schichtarbeit,QUlEPTIwMTE1NCZNSUQ9MTEwNTc2.html

  4. Ellis JG, Gherman P, Espie CA, Riemann D, Perlis ML (2012) Acute insomnia: current conceptualizations and future directions. Sleep Med Rev 16:5–14

    Article  PubMed  Google Scholar 

  5. Espie CA, Broomfield NM, MacMahon KM, Macphee LM, Taylor LM (2006) The attention-intention-effort pathway in the development of psychophysiologic insomnia: a theoretical review. Sleep Med Rev 10:215–245

    Article  PubMed  Google Scholar 

  6. Feige B, Baglioni C, Spiegelhalder K, Hirscher V, Nissen C, Riemann D (2013) The microstructure of sleep in primary insomnia: an overview and extension. Int J Psychophysiol 89:171–180

    Article  PubMed  Google Scholar 

  7. Harvey AG (2002) A cognitive model of insomnia. Behav Res Ther 40:869–893

    Article  CAS  PubMed  Google Scholar 

  8. Levenson JC, Kay DB, Buysse DJ (2015) The pathophysiology of insomnia. Chest 147:1179–1192

    Article  PubMed  PubMed Central  Google Scholar 

  9. Morin CM, Benca R (2012) Chronic insomnia. Lancet 379:1129–1141

    Article  PubMed  Google Scholar 

  10. Morin CM, Drake CL, Harvey AG, Krystal AD, Manber R, Riemann D, Spiegelhalder K (2015) Insomnia disorder. Nat Rev Dis Primers 1:15026. doi:10.1038/nrdp.2015.26

    Article  PubMed  Google Scholar 

  11. Palagini L, Biber K, Riemann D (2014) The genetics of insomnia – evidence for epigenetic mechanisms? Sleep Med Rev 18(3):225–235. doi:10.1016/j.smrv.2013.05.002

    Article  PubMed  Google Scholar 

  12. Perlis ML, Giles DE, Mendelson WB, Bootzin RR, Wyatt JK (1997) Psychophysiological insomnia: the behavioural model and a neurocognitive perspective. J Sleep Res 6:179–188

    Article  CAS  PubMed  Google Scholar 

  13. Riemann D, Spiegelhalder K, Feige B, Voderholzer U, Berger M, Perlis M, Nissen C (2010) The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 14:19–31

    Article  PubMed  Google Scholar 

  14. Riemann D, Spiegelhalder K, Nissen C, Hirscher V, Baglioni C, Feige B (2012) REM sleep instability – a new pathway for insomnia? Pharmacopsychiatry 45:167–176

    CAS  PubMed  Google Scholar 

  15. Riemann D, Spiegelhalder K, Espie C, Pollmächer T, Léger D, Bassetti C, van Someren E (2011) Chronic insomnia: clinical and research challenges – an agenda. Pharmacopsychiatry 44:1–14

    Article  CAS  PubMed  Google Scholar 

  16. Riemann D, Nissen C, Palagini L, Otte A, Perlis ML, Spiegelhalder K (2015) The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol 14:547–558

    Article  PubMed  Google Scholar 

  17. Saper CB, Scammell TE, Lu J (2005) Hypothalamic regulation of sleep a‑nd circadian rhythms. Nature 437:1257–1263

    Article  CAS  PubMed  Google Scholar 

  18. Sateia MJ, Nowell PD (2004) Insomnia. Lancet 364:1959–1973

    Article  PubMed  Google Scholar 

  19. Silber MH (2005) Chronic insomnia. New Engl J Med 353:803–810

    Article  CAS  PubMed  Google Scholar 

  20. Spielman AJ, Caruso LS, Glovinsky PA (1987) A behavioral perspective on insomnia treatment. Psychiatr Clin North Am 10:541–553

    CAS  PubMed  Google Scholar 

  21. Winkelman JW (2015) Insomnia disorder. N Engl J Med 373:1437–1444

    Article  CAS  PubMed  Google Scholar 

2.2. Begriffsbestimmung und diagnostische Klassifikationssysteme

  1. American Psychiatric Association (Hrsg) (2013) DSM 5 (diagnostic and statistical manual of mental disorders). American Psychiatric Association, Washington DC

    Google Scholar 

  2. WHO (1992) Kapitel V–F 51.0 Insomnien. In: ICD-10 (international statistical classification of diseases and related health problems). WHO, Genf

    Google Scholar 

  3. American Academy of Sleep Medicine (Hrsg) (2014) ICSD-3 (International Classification of Sleep ICSD-2 Disorders). American Association of Sleep Medicine, Darien

    Google Scholar 

  4. National Institutes of Health (2005) National Institutes of Health state of the science conference statement: manifestations and management of chronic insomnia in adults June 13–15, 2005. Sleep 28:1049–1057

    Google Scholar 

2.3. Diagnostik und Differentialdiagnostik

  1. Baglioni C, Regen W, Teghen A, Spiegelhalder K, Feige B, Nissen C, Riemann D (2014) Sleep changes in the disorder of insomnia: a meta-analysis of polysomnographic studies. Sleep Med Rev 18:195–213

    Article  PubMed  Google Scholar 

  2. Bastien CH, Vallières A, Morin CM (2001) Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med 2:297–307

    Article  PubMed  Google Scholar 

  3. Benca RM, Obermeyer WH, Thisted RA, Gillin JC (1992) Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry 49:651–668

    Article  CAS  PubMed  Google Scholar 

  4. Buysse DJ, Reynolds CF, Monk TH et al (1989) The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213

    Article  CAS  PubMed  Google Scholar 

  5. Carney CE, Buysse DJ, Ancoli-Israel S, Edinger JD, Krystal AD, Lichstein K, Morin CM (2012) The consensus sleep diary: standardizing prospective sleep self-monitoring. Sleep 35:287–302

    PubMed  PubMed Central  Google Scholar 

  6. Crönlein T, Geisler P, Langguth B, Eichhammer P, Jara C, Pieh C, Zulley J, Hajak G (2012) Polysomnography reveals unexpectedly high rates of organic sleep disorders in patients with prediagnosed primary insomnia. Sleep Breath 16:1097–1103

    Article  PubMed  Google Scholar 

  7. Feige B, Al-Shajlawi A, Nissen C, Voderholzer U, Hornyak M, Spiegelhalder K, Kloepfer C, Perlis M, Riemann D (2008) Does REM sleep contribute to subjective wake time in primary insomnia? A comparison of polysomnographic and subjective sleep in 100 patients. J Sleep Res 17:180–190

    Article  PubMed  Google Scholar 

  8. Görtelmeyer R (2005) Schlaffragebogen A und B. In: CIPS: Internationale Skalen für Psychiatrie, 5. Aufl. Beltz PVU, Weinheim, S 537–370

    Google Scholar 

  9. Hoffmann RM, Müller T, Hajak G, Cassel W (1997) Abend-Morgenprotokolle in Schlafforschung und Schlafmedizin – Ein Standardinstrument für den deutschsprachigen Raum. Somnologie (Berl) 1:103–109

    Article  Google Scholar 

  10. Kolla BP, Mansukhani S, Mansukhani MP (2016) Consumer sleep tracking devices: a review of mechanisms, validity and utility. Expert Rev Med Devices 13(5):497–506. doi:10.1586/17434440.2016.1171708

    Article  CAS  PubMed  Google Scholar 

  11. Liendl S, Hoffmann RM (1999) Compliance-Probleme bei der Bearbeitung von Abend-Morgen-Protokollen – Entwicklung einer Kurzversion der Standardprotokolle der DGSM. Somnologie (Berl) 3:73–77

    Article  Google Scholar 

  12. Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B, Brown T, Chesson A Jr, Coleman J, Lee-Chiong T, Pancer J, Swick TJ (2007) Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep 30:519–529

    Article  PubMed  Google Scholar 

  13. Ohayon MM, Roth T (2013) Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 37:9–15

    Article  Google Scholar 

  14. Shahid A, Wilkinson K, Marcu S, Shapiro CM (Hrsg) (2012) STOP, THAT and one hundred other sleep scales. Springer, New York

    Google Scholar 

2.4. Epidemiologie – Risikofaktoren

  1. Morin CM, Bélanger L, LeBlanc M, Ivers H, Savard J, Espie CA, Mérette C, Baillargeon L, Grégoire J‑P (2009) The natural history of insomnia. Arch Intern Med 169:447–453

    Article  PubMed  Google Scholar 

  2. Ohayon MM (2002) Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6:97–111

    Article  PubMed  Google Scholar 

  3. Schlack R, Hapke U, Maske U, Busch MA, Cohrs S (2013) Häufigkeit und Verteilung von Schlafproblemen und Insomnie in der deutschen Erwachsenenbevölkerung. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 5(6):740–748

    Article  Google Scholar 

  4. Thun E, Bjorvatn B, Akerstedt T, Moen BE, Waage S, Molde H, Pallesen S (2016) Trajectories of sleepiness and insomnia symptoms in Norwegian nurses with and without night work and rotational work. Chronobiol Int 33:480–489

    Article  PubMed  Google Scholar 

2.5. Gesundheitsrisiken

  1. Anothaisintawee T, Reutrakul S, Van Cauter E, Thakkinstian A (2015) Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis. Sleep Med Rev 30:11–24

    Article  PubMed  Google Scholar 

  2. Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, Lombardo C, Riemann D (2011) Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord 135:10–19

    Article  PubMed  Google Scholar 

  3. Bernert RA, Turvey CL, Conwell Y, Joiner TE (2014) Association of poor subjective sleep quality with risk for death by suicide during a 10-year period – a longitudinal, population-based study of late life. JAMA Psychiatry 71:1129–1137

    Article  PubMed  PubMed Central  Google Scholar 

  4. Bjørngaard JH, Bjerkeset O, Romundstad P, Gunnell D (2011) Sleeping problems and suicide in 75,000 Norwegian adults: a 20 year follow-up of the HUNT I study. Sleep 34:1155–1159

    PubMed  PubMed Central  Google Scholar 

  5. Chen X, Beydoun MA, Wang Y (2008) Is sleep duration associated with childhood obesity? A systematic review and meta-analysis. Obesity (Silver Spring) 16:265–274

    Article  Google Scholar 

  6. Crönlein T, Langguth B, Busch V, Rupprecht R, Wetter TC (2015) Severe chronic insomnia is not associated with higher body mass index. J Sleep Res 24:514–517

    Article  PubMed  Google Scholar 

  7. Laugsand LE, Vatten LJ, Platou C, Janszky I (2011) Insomnia and the risk of acute myocardial infarction: a population study. Circulation 124:2073–2081

    Article  PubMed  Google Scholar 

  8. Laugsand LE, Strand LB, Platou C, Vatten LJ, Janszky I (2014a) Insomnia and the risk of incident heart failure: A population study. Eur Heart J 35:1382–1393

    Article  PubMed  Google Scholar 

  9. Laugsand LE, Strand LB, Vatten LJ, Janszky I, Bjørngaard JH (2014b) Insomnia symptoms and risk for unintentional fatal injuries – The HUNT Study. Sleep 37:1777–1786

    PubMed  PubMed Central  Google Scholar 

  10. Li M, Zhang X‑W, Hou W‑S, Tang Z‑Y (2014) Insomnia and risk of cardiovascular disease: a meta-analysis of cohort studies. Int J Cardiol 176:1044–1047

    Article  PubMed  Google Scholar 

  11. Malik S, Kanwar A, Sim LA, Prokop LJ, Wang Z, Benkhadra K (2014) The association between sleep disturbances and suicidal behaviors in patients with psychiatric diagnoses: a systematic review and meta-analysis. Syst Rev 3:1–9

    Article  Google Scholar 

  12. Mayer G, Jennum P, Riemann D, Cauvilliers Y (2011) Insomnia in central neurologic diseases – occurrence and management. Sleep Med Rev 15:369–378

    Article  PubMed  Google Scholar 

  13. Meng L, Zheng Y, Hui R (2013) The relationship of sleep duration and insomnia to risk of hypertension incidence: a meta-analysis of prospective cohort studies. Hypertens Res 36:985–995

    Article  PubMed  PubMed Central  Google Scholar 

  14. Neckelmann D, Mykletun A, Dahl AA (2007) Chronic insomnia as a risk factor for developing anxiety and depression. Sleep 30:873–880

    PubMed  PubMed Central  Google Scholar 

  15. Palagini L, Bruno RM, Gemignani A, Baglioni C, Ghiadoni L, Riemann D (2013) Sleep loss and hypertension: a systematic review. Curr Pharm Des 19:2409–2419

    Article  CAS  PubMed  Google Scholar 

  16. Patel SR, Hu FB (2008) Short sleep duration and weight gain: a systematic review. Obesity (Silver Spring) 16:643–653

    Article  Google Scholar 

  17. Riemann D, Voderholzer U (2003) Primary insomnia: a risk factor to develop depression? J Affect Disord 76:255–259

    Article  PubMed  Google Scholar 

  18. Pigeon WR, Pinquart M, Conner K (2012) Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. J Clin Psychiatry 73:1160–1167

    Article  Google Scholar 

  19. Sexton CE, Storsve AB, Walhovd KB et al (2014) Poor sleep quality is associated with increased cortical atrophy in community-dwelling adults. Neurology 83:967–973

    Article  PubMed  PubMed Central  Google Scholar 

  20. Sivertsen B, Øverland S, Pallesen S, Bjorvatn B, Nordnus IH, MÆland JG, Mykletun A (2009a) Insomnia and long sleep duration are risk factors for later work disability. The Hordaland Health Study. J Sleep Res 18:122–128

    Article  PubMed  Google Scholar 

  21. Sivertsen B, Øverland S, Bjorvatn B, MÆland JG, Mykletun A (2009b) Does insomnia predict sick leave? The Hordaland Health Study. J Psychosom Res 66:67–74

    Article  PubMed  Google Scholar 

  22. Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF (2014) Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol 21:57–64

    Article  PubMed  Google Scholar 

  23. Weissman MM, Greenwald S, Niño-Murcia G, Dement WC (1997) The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 19:245–250

    Article  CAS  PubMed  Google Scholar 

  24. Yaffe K, Falvey CM, Hoang T (2014) Connections between sleep and cognition in older adults. Lancet Neurol 13:1017–1028

    Article  PubMed  Google Scholar 

2.6. Kosten

  1. Collins PY, Patel V, Joestl SS (2011) Grand challenges in global mental health. Nature 475:27–30

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Daley M, Morin CM, LeBlanc M, Grégoire J‑P, Savard J (2009) The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms and good sleepers. Sleep 32:55–64

    PubMed  PubMed Central  Google Scholar 

  3. Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen H‑C, Stovner LJ, Vallat J‑M, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen H‑U, Jönsson B, Olesen J (2011) Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21:718–779

    Article  CAS  PubMed  Google Scholar 

  4. Léger D, Bayon V (2010) Societal costs of insomnia. Sleep Med Rev 14:379–389

    Article  PubMed  Google Scholar 

  5. Ozminkowski RJ, Wang S, Walsh JK (2007) The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 30:263–273

    PubMed  Google Scholar 

2.7.1. Kognitive Verhaltenstherapie

  1. Backhaus J, Hohagen F, Voderholzer U, Riemann D (2001) Long-term effectiveness of a short-term cognitive-behavioral group treatment for primary insomnia. Eur Arch Psychiatry Clin Neurosci 251:35–41

    Article  CAS  PubMed  Google Scholar 

  2. Belleville G, Cousineau H, Levrier K, St. Pierre-Delorme ME (2011) Meta-analytic review of the impact of cognitive-behaviour therapy for insomnia on concomitant anxiety. Clin Psychol Rev 31:638–652

    Article  PubMed  Google Scholar 

  3. Borbély AA (1982) A two process model of sleep regulation. Hum Neurobiol 1:195–204

    PubMed  Google Scholar 

  4. Borbély AA, Achermann P (1999) Sleep homeostasis and models of sleep regulation. J Biol Rhythms 14:557–568

    PubMed  Google Scholar 

  5. Buysse DJ, Germain A, Moul DE, Franzen PL, Brar LK, Fletcher ME, Begley A, Houck PR, Mazumdar S, Reynolds CF, Monk TH (2011) Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med 171:887–895

    Article  PubMed  PubMed Central  Google Scholar 

  6. Cheng SK, Dizon J (2012) Computerised cognitive behavioural therapy for insomnia: a systematic review and meta-analysis. Psychother Psychosom 81:206–216

    Article  PubMed  Google Scholar 

  7. Christensen H, Batterham PJ, Gosling JA, Ritterband LM, Griffiths KM, Thorndike FP, Glozier N, O’Dea B, Hickie IB, Mackinnon AJ (2016) Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trial. Lancet Psychiatry 3(4):333–341. doi:10.1016/S2215-0366(15)00536-2

    Article  PubMed  Google Scholar 

  8. Crönlein T (2013) Primäre Insomnie – Ein Gruppentherapieprogramm für den stationären Bereich. Hogrefe, Göttingen

    Google Scholar 

  9. Crönlein T, Langguth B, Geisler P, Wetter TC, Eichhammer P (2014) Fourteen-day inpatient cognitive-behavioural therapy for insomnia: a logical and useful extension of the stepped-care approach for the treatment of insomnia. Psychother Psychosom 83:255–256

    Article  PubMed  Google Scholar 

  10. Ellis JG, Cushing T, Germain A (2015) Treating acute insomnia: a randomized controlled trial of a „single-shot“ of cognitive behavioral therapy for insomnia. Sleep 38:971–978

    PubMed  PubMed Central  Google Scholar 

  11. Espie CA, MacMahon KMA, Kelly H‑L, Broomfield NM, Douglas NJ, Engleman HM, McKinstry B, Morin CM, Walker A, Wilson P (2007) Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep 30:574–584

    PubMed  Google Scholar 

  12. Espie CA, Kyle SD, Williams C, Ong JC, Douglas NJ, Hames P, Brown JSL (2012) A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep 35:769–781

    Article  PubMed  PubMed Central  Google Scholar 

  13. Geiger-Brown JM, Rogers VE, Liu W, Ludeman EM, Downton KD, Diaz-Abad M (2015) Cognitive behavioral therapy in persons with comorbid insomnia: a meta-analysis. Sleep Med Rev 23:54–67

    Article  PubMed  Google Scholar 

  14. Gosling JA, Glozier N, Griffiths K, Ritterband L, Thorndike F, Mackinnon A, Hehir KK, Bennett A, Bennett K, Christensen H (2014) The GoodNight study – online CBT for insomnia for the indicated prevention of depression: study protocol for a randomized controlled trial. Trials 15:56. doi:10.1186/1745-6215-15-56

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hauri PJ (1991) Case studies in insomnia. Plenum Medical Book Company, New York

    Book  Google Scholar 

  16. Hertenstein E, Spiegelhalder K, Johann A, Riemann D (2015) Prävention und Psychotherapie der Insomnie. Kohlhammer, Stuttgart

    Google Scholar 

  17. Ho FY, Chan CS, Tang KN (2016) Cognitive-behavioral therapy for sleep disturbances in treating posttraumatic stress disorder symptoms: a meta-analysis of randomized controlled trials. Clin Psychol Rev 43:90–102. doi:10.1016/j.cpr.2015.09.005

    Article  PubMed  Google Scholar 

  18. Ho FY, Chung K‑F, Yeung W‑F, Ng TH, Kwan K‑S, Yung K‑P, Cheng SK (2015) Self-help cognitive-behavioral therapy for insomnia: a meta-analysis of randomized controlled trials. Sleep Med Rev 19:17–28

    Article  PubMed  Google Scholar 

  19. Irwin MR, Cole JC, Nicassio PM (2006) Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults an in older adults 55+ years of age. Health Psychol 25:3–14

    Article  PubMed  Google Scholar 

  20. Irish LA, Kline CE, Gunn HE, Buysse DJ, Hall MH (2015) The role of sleep hygiene in promoting public health: a review of empirical evidence. Sleep Med Rev 22:2–36

    Article  Google Scholar 

  21. Järnefelt H, Lagerstedt R, Kajaste S, Sallinen M, Savolainen A, Hublin C (2012) Cognitive behavioral therapy for shift workers with chronic insomnia. Sleep Med 13:1238–1246

    Article  PubMed  Google Scholar 

  22. Johnson JA, Rash JA, Campbell TS, Savard J, Gehrman PR, Perlis M, Carlson LE, Garland SN (2016) A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev 27:20–28

    Article  PubMed  Google Scholar 

  23. Koffel EA, Koffel JB, Gehrman PR (2015) A meta-analysis of group cognitive behavioral therapy for insomnia. Sleep Med Rev 19:6–16

    Article  PubMed  Google Scholar 

  24. Lacks P, Rotert M (1986) Knowledge and practice of sleep hygiene techniques in insomniacs and good sleepers. Behav Res Ther 24:365–368

    Article  CAS  PubMed  Google Scholar 

  25. Miller CB, Espie CA, Epstein DR, Friedman L, Morin CM, Pigeon WR, Spielman AJ, Kyle SD (2014) The evidence base of sleep restriction therapy for treating insomnia disorder. Sleep Med Rev 18(5):415–424. doi:10.1016/j.smrv.2014.01.006

    Article  PubMed  Google Scholar 

  26. Mitchell MD, Gehrman P, Perlis ML, Umscheid CA (2012) Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic reveiw. BMC Fam Pract 13(40):1–11

    Google Scholar 

  27. Montgomery P, Dennis J (2004) A systematic review of non-pharmacological therapies for sleep problems in later life. Sleep Med Rev 8:47–62

    Article  PubMed  Google Scholar 

  28. Morgenthaler T, Kramer M, Alessi C, Friedman L, Boehlecke B, Brown T, Coleman J, Kapur V, Lee-Chiong T, Owens J, Pancer J, Swick T (2006) Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of Sleep medicine report. Sleep 29:1415–1419

    PubMed  Google Scholar 

  29. Morin CM, Culbert JP, Schwartz SM (1994) Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 151:1172–1180

    Article  CAS  PubMed  Google Scholar 

  30. Morin CM, Colecchi C, Stone J, Sood R, Brink D (1999) Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 281:991–999

    Article  CAS  PubMed  Google Scholar 

  31. Morin CM, Vallières A, Guay B, Ivers H, Savard J, Mérette C, Bastien C, Baillargeon L (2009) Cognitive behanvioral therapy, singly and combined with medication, for persistent insomnia. JAMA 301:2005–2015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Müller T, Paterok B (1999) Schlaftraining – Ein Therapiemanual zur Behandlung von Schlafstörungen. Hogrefe, Göttingen

    Google Scholar 

  33. Murtagh DRR, Greenwood KM (1995) Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol 63:79–89

    Article  CAS  PubMed  Google Scholar 

  34. Okajima I, Komada Y, Inoue Y (2011) A meta-analysis on the treatment effectiveness of cognitive behavioral therapy for primary insomnia. Sleep Biol Rhythms 9:24–34

    Article  Google Scholar 

  35. Pallesen S, Nordhus IH, Kvale G (1998) Nonpharmacological interventions for insomnia in older adults: a meta-analysisn of treatment efficacy. Psychotherapy (Chic) 35:472

    Article  Google Scholar 

  36. Riemann D (2016) Ratgeber Schlafstörungen - Informationen für Betroffene und Angehörige, 2. Aufl. Hogrefe, Göttingen

    Book  Google Scholar 

  37. Riemann D, Perlis ML (2009) The treatments of chronic insomnia: a review of benzo-diazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev 13:205–214

    Article  PubMed  Google Scholar 

  38. Ritterband LM, Thorndike FP, Gonder-Frederick LA, Magee JC, Bailey ET, Saylor DK, Morin CM (2009) Efficacy of an internet-based behavioral intervention for adults with insomnia. Arch Gen Psychiatry 66:692–698

    Article  PubMed  PubMed Central  Google Scholar 

  39. Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, Buysse DJ (2002) Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 159:5–11

    Article  PubMed  Google Scholar 

  40. Spiegelhalder K, Backhaus J, Riemann D (2011) Schlafstörungen – Fortschritte der Psychotherapie. Hogrefe, Göttingen

    Google Scholar 

  41. Stiftung Warentest (2016) Endlich schlafen. Stiftung Warentest, Berlin

    Google Scholar 

  42. Tang NKY, Lereya ST, Boulton H, Miller MA, Wolke D, Cappuccio FP (2015) Nonpharmacological treatments of insomnia for long-term painful conditions: a systematic review and meta-analysis of patient-reported outcomes in randomized controlled trials. Sleep 38:1751–1764

    Article  PubMed  PubMed Central  Google Scholar 

  43. Trauer JM, Qian MY, Doyle JS, Rajaratnam SMW (2015) Cognitive behavioral therapy for chronic insomnia. Ann Intern Med 163:191–204

    Article  PubMed  Google Scholar 

  44. Van Straten A, Cuijpers P (2009) Self-help therapy for insomnia: a meta-analysis. Sleep Med Rev 13:61–71

    Article  PubMed  Google Scholar 

  45. Wu JQ, Appleman ER, Salazar RD, Ong JC (2015) Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions. JAMA Intern Med 175(1461):1472

    Google Scholar 

  46. Ye Y, Zhang Y, Chen J, Liu J, Li X, Liu Y, Lang Y, Lin L, Yang X, Jiang X (2015) Internet-based cognitive behavioral therapy for insomnia (ICBT-I) improves comorbid anxiety and depression – a meta-analysis of randomized controlled trials. PLOS ONE 10:eO142258. doi:10.1371/journal.pone.0142258

    Google Scholar 

  47. Zachariae R, Lyby MS, Ritterband LM, O’Toole MS (2016) Efficacy of internet-delivered cognitive-behavioral therapy for insomnia – A systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev 30:1–10. doi:10.1016/j.smrv.2015.10.004

2.7.2. Pharmakotherapie der Insomnie

  1. Belanger L, Vallieres A, Ivers H, Moreau V, Lavigne G, Morin CM (2007) Meta-analysis of sleep changes in control groups of insomnia treatment trials. J Sleep Res 16:77–84

    Article  PubMed  Google Scholar 

  2. Hróbjartsson A, Gøtzsche PC (2001) Is the placebo powerless? N Engl J Med 344:1594–1602

    Article  PubMed  Google Scholar 

  3. Mattila T, Stoyanova V, Elferink A, Gispen-de Wied C, de Boer A, Wohlfarth T (2011) Insomnia medication: Do published studies reflect the complete picture of efficacy and safety? Eur Neuropsychopharmacol 21:500–5007

    Article  CAS  PubMed  Google Scholar 

  4. McCall WV, D’Agostino R, Dunn A (2003) A meta-analysis of sleep changes associated with placebo in hypnotic clinical trials. Sleep Med 4:57–62

    Article  PubMed  Google Scholar 

  5. Nissen C, Frase L, Hajak G, Wetter TC (2014) Hypnotika – Stand der Forschung. Nervenarzt 85:67–76

    Article  CAS  PubMed  Google Scholar 

  6. Riemann D, Riemann D, Nissen C (2012) Sleep and psychotropic drugs. In: Morin CM, Espie CA (Hrsg) Oxford handbook of sleep and sleep disorders. Oxford University Press, Oxford

    Google Scholar 

  7. Winkler A, Rief W (2015) Effect of placebo conditions on polysomnographic parameters in primary insomnia: a meta-analysis. Sleep 38:925–931

    PubMed  PubMed Central  Google Scholar 

2.7.2.1. Benzodiazepine und Benzodiazepin-Rezeptor-Agonisten

  1. Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, Klassen TP, Witmans M (2007) The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 22(9):1335–1350. doi:10.1007/s11606-007-0251-z

    Article  PubMed  PubMed Central  Google Scholar 

  2. Dündar Y, Dodd S, Strobl J, Boland A, Dickson R, Walley T (2004) Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Hum Psychopharmacol 19:305–322

    Article  PubMed  CAS  Google Scholar 

  3. Glass J, Lanctôt KL, Hermann N, Sproule BA, Busto UE (2005) Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. Br Med J 331:1–7

    Article  Google Scholar 

  4. Holbrook AM, Crowther R, Lotter A, Cheng C, King D (2000) Meta-analysis of benzodiazepine use in the treatment of insomnia. Can Med Assoc J 162:225–233

    CAS  Google Scholar 

  5. Huedo-Medina T, Kirsch I, Klonizakis M, Siriwardena AN (2012) Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. Br Med J 345:1–13

    Article  CAS  Google Scholar 

  6. Nowell PD, Mazumdar S, Buysse DJ, Dew MA (1997) Benzodiazepines and zolpidem for chronic insomnia – a meta-analysis of treatment efficacy. JAMA 278:2170–2177

    Article  CAS  PubMed  Google Scholar 

  7. Winkler A, Auer C, Doering BK, Rief W (2014) Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials. CNS Drugs 28:799–816

    Article  CAS  PubMed  Google Scholar 

2.7.2.2. Sedierende Antidepressiva

  1. Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, Klassen TP, Witmans M (2007) The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 22(9):1335–1350. doi:10.1007/s11606-007-0251-z

    Article  PubMed  PubMed Central  Google Scholar 

  2. McCleery J, Cohen DA, Sharpley AL (2014) Pharmacotherapies for sleep disturbances in Alzheimer’s disease (review). Cochrane Database Syst Rev. doi:10.1002/14651858.cd009178.pub2

    PubMed  Google Scholar 

  3. Winkler A, Auer C, Doering BK, Rief W (2014) Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials. CNS Drugs 28:799–816

    Article  CAS  PubMed  Google Scholar 

  4. Yeung W‑F, Chung K‑F, Yung K‑P, Ng T (2015) Doxepin for insomnia: a systematic review of randomized placebo-controlled trials. Sleep Med Rev 19:75–83

    Article  PubMed  Google Scholar 

2.7.2.3. Neuroleptika

  1. Anderson SL, Vande Griend JP (2014) Quetiapine for insomnia: a review of the literature. Am J Health Syst Pharm 71:394–402

    Article  CAS  PubMed  Google Scholar 

  2. Cohrs S (2008) Sleep disturbances in patients with schizophrenia. Impact and effects of antipsychotics. CNS Drugs 22:939–962

    Article  CAS  PubMed  Google Scholar 

  3. Monti JM, Monti D (2004) Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Med Rev 8:133–148

    Article  PubMed  Google Scholar 

2.7.2.4. Antihistaminika

  1. Vande Griend JP, Anderson SL (2003) Histamine-1 receptor antagonism for treatment of insomnia. J Am Pharm Assoc 52:210–219

    Article  Google Scholar 

2.7.2.5. Phytotherapeutika

  1. Bent S, Padula A, Moore D, Patterson M, Mehling W (2006) Valerian for sleep: a systematic review and meta-analysis. Am J Med 119:1005–1012

    Article  PubMed  PubMed Central  Google Scholar 

  2. Fernández-San-Martín MI, Masa-Font R, Palacios-Soler L, Sancho-Gómez P, Calbó-Caldentey C, Flores-Mateo G (2010) Effectiveness of valerian on insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med 11:505–511

    Article  PubMed  Google Scholar 

  3. Leach MJ, Page AT (2015) Herbal medicine for insomnia: a systematic review and meta-analysis. Sleep Med Rev 24:1–12

    Article  PubMed  Google Scholar 

  4. Ni X, Shergis JL, Guo X, Zhang AL, Li Y, Lu C, Xue CC (2015) Updated clinical evidence of Chinese herbal medicine for insomnia: a systematic review and meta-analysis of randomized controlled trials. Sleep Med 16:1462–1481

    Article  PubMed  Google Scholar 

2.7.2.6. Melatonin

  1. Braam W, Smits MG, Didden R, Korzilius H, van Geijlswijk IM, Curfs LMG (2009) Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis. Dev Med Child Neurol 51:340–348

    Article  PubMed  Google Scholar 

  2. Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, Ford I (2005) Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev 9:41–50

    Article  PubMed  Google Scholar 

  3. Buscemi N, Vandermeer B, Hootin N, Pandya R, Tjosvold L, Hartling L, Baker G, Klassen TP, Vohra S (2005) The efficacy and safety of exogenous melatonin for primary sleep disorders – a meta-analysis. J Gen Intern Med 20:1151–1158

    Article  PubMed  PubMed Central  Google Scholar 

  4. Buscemi N, Vandermeer B, Hootin N, Pandya R, Tjosvold L, Hartling L, Vohra S, Klassen TP, Baker G (2006) Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. Br Med J 332:385–393

    Article  CAS  Google Scholar 

  5. European Medicines Agency (2015) Public summary of opinion on orphan designation: Tasimelteon for the treatment of non-24-hour sleep-wake disorder in blind people with no light perception. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2011/03/human_orphan_000903.jsp&mid=WC0b01ac058001d12b. Zugegriffen: 31.01.2016

    Google Scholar 

  6. Ferracioli-Oda E, Qawasmi A, Bloch MH (2013) Meta-analysis: melatonin for the treatment of primary sleep disorders. PLOS ONE 8:e63773

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Geijlswijk IM, Korzilius HPLM, Smits MG (2010) The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. Sleep 33:1605–1614

    PubMed  PubMed Central  Google Scholar 

  8. Kuriyama A, Honda M, Hayashino Y (2014) Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis. Sleep Med 15:385–392

    Article  PubMed  Google Scholar 

  9. Liu J, Wang L‑N (2012) Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis. Int J Clin Pract 66:867–873

    Article  CAS  PubMed  Google Scholar 

  10. McCleery J, Cohen DA, Sharpley AL (2014) Pharmacotherapies for sleep disturbances in Alzheimer’s disease (review). Cochrane Database Syst Rev. doi:10.1002/14651858.cd009178.pub2

    PubMed  Google Scholar 

  11. Zhang W, Chen XY, Su SW, Jia QZ, Ding T, Zhu ZN, Zhang T (2015) Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials. Neurol Sci 37(1):57–65. doi:10.1007/s10072-015-2357-0

    Article  PubMed  Google Scholar 

2.7.3. Weitere Therapieverfahren

  1. Chen HY, Shi XY, Ng CS, Chan SM, Yung KK, Zhang QL (2007) Auricular acupuncture treatment for insomnia: a systematic review. J Altern Complement Med 13:669–676

    Article  PubMed  Google Scholar 

  2. Cheuk DKL, Yeung WF, Chung KF, Wong V (2012) Acupuncture for insomnia (review). Cochrane Database Syst Rev 9. doi:10.1002/14651858.cd005472.pub3

    Google Scholar 

  3. Cooper KL, Relton C (2010) Homeopathy for insomnia: a systematic review of research evidence. Sleep Med Rev 14:329–337

    Article  PubMed  Google Scholar 

  4. De Niet G, Tiemens B, Lendemeijer B, Hutschemaekers G (2009) Music-assisted relaxation to improve sleep quality: meta-analysis. J Adv Nurs 65:1356–1364

    Article  PubMed  Google Scholar 

  5. Ernst E (2011) Homeopathy for insomnia and sleeprelated disorders: a systematic review of randomized controlled trials. Focus Altern Complement Ther 16:195–199

    Article  Google Scholar 

  6. Hwang E, Shin S (2015) The effects of aromatherapy on sleep improvement: a systematic literature review and meta-analysis. J Altern Complement Med 21:61–68

    Article  PubMed  Google Scholar 

  7. Jespersen KV, Koenig J, Jennum P, Vuust P (2015) The Cochrane collaboration: music for insomnia in adults (review). John Wiley & Sons, Chichester

    Google Scholar 

  8. Kanen JW, Nazir R, Sedkys K, Pradhan BK (2015) The effects of mindfulness-based interventions on sleep disturbance: a meta-analysis. Adolesc Psychiatry 5:105–115

    Article  Google Scholar 

  9. Kredlow MA, Capozzoli MC, Hearon BA, Calkins AW, Otto MW (2015) The effects of physical activity on sleep: a meta-analytic review. J Behav Med 38:427–449

    Article  PubMed  Google Scholar 

  10. Lam T‑H, Chung K‑F, Yeung W‑F, Yu BY-M, Yung K‑P, Ng TH-Y (2015) Hypnotherapy for insomnia: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med 23:719–732

    Article  PubMed  Google Scholar 

  11. Lan Y, Tan HT, Wu N, Xing JJ, Wu FS, Zhang LX, Liang FR (2015) Auricular acupuncture with seed or pellet attachments for primary insomnia: a systematic review and meta-analysis. BMC Complement Altern Med 15:103. doi:10.1186/s12906-015-0606-7

    Article  PubMed  PubMed Central  Google Scholar 

  12. Lee J, Han M, Chung Y, Kim J, Choi J (2011) Effects of foot reflexology on fatigue, sleep and pain: a systematic review and meta-analysis. J Korean Acad Nurs 41:821–833

    Article  PubMed  Google Scholar 

  13. Lillehei AS, Halcon LL (2014) A systematic review of the effect of inhaled essential oils on sleep. J Altern Complement Med 20:441–451

    Article  PubMed  Google Scholar 

  14. Van Maanen A, Meijer AM, van der Heijden KB, Ooort FJ (2016) The effects of light therapy on sleep problems: a systematic review and meta-analysis. Sleep Med Rev 29:52–62

    Article  PubMed  Google Scholar 

  15. Wang C‑F, Sun Y‑L, Zang H‑X (2014) Music therapy improves sleep quality in acute and chronic sleep disorders: a meta-analysis of 10 randomized studies. Int J Nurs Stud 51:51–62

    Article  CAS  PubMed  Google Scholar 

  16. Wang F, Lee OE-K, Feng F, Vitiello MV, Wang W, Benson H, Fricchione GL, Denninger JW (2016) The effect of meditative movement on sleep quality: a systematic review. Sleep Med Rev 30:43–52

    Article  PubMed  Google Scholar 

  17. Wu WW, Kwong E, Lan XY, Jiang XY (2015) The effect of meditative movement intervention on quality of sleep in the elderly: a systematic review and meta-analysis. J Altern Complement Med 21:509–519

    Article  PubMed  Google Scholar 

  18. Yeung W‑F, Chung K‑F, Poon MM-K, Ho FY-Y, Zhang S‑P, Zhang Z‑J, Ziea ET-C, Wong VT (2012) Acupressure, reflexology, and auricular acupressure for insomnia: a systematic review of randomized controlled trials. Sleep Med 13:971–984

    Article  PubMed  Google Scholar 

2.7.4. Langzeittherapie von Insomnien mit Hypnotika

  1. Ancoli-Insrael S, Krystal AD, McCall WV, Schaefer K, Wilson A, Rubens RCR, Roth T (2010) A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia. Sleep 33:225–234

    Google Scholar 

  2. Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T (2003) Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 26:793–799

    PubMed  Google Scholar 

  3. Krystal AD, Erman M, Zammit GK, Soubrane C, Roth R (2008) Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: A 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep 31:79–90

    PubMed  PubMed Central  Google Scholar 

  4. Krystal AD, Durrence HH, Scharf M, Jochelson P, Rogowski R, Ludington E, Roth T (2010) Efficacy and safety of doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia. Sleep 33:1553–1561

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mayer G, Wang-Weigand S, Roth-Schechter B, Lehmann R, Staner C, Partinen M (2009) Efficacy and safety of 6‑month nightly ramelteon administration in adults with chronic primary insomnia. Sleep 32:351–360

    PubMed  PubMed Central  Google Scholar 

  6. Michelson D, Snyder E, Paradis E, Chengan-Liu M, Snavely DB, Hutzelmann J, Walsh JK, Krystal AD, Benca RM, Cohn M, Lines C, Roth T, Herring WJ (2014) Safety and efficacy of suvorexant during 1‑year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet Neurol 13:461–471

    Article  CAS  PubMed  Google Scholar 

  7. Perlis ML, McCall WV, Krystal AD, Walsh JK (2004) Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatry 65:1128–1137

    Article  CAS  PubMed  Google Scholar 

  8. Randall S, Roehrs TA, Roth T (2012) Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study. Sleep 35:1551–1557

    PubMed  PubMed Central  Google Scholar 

  9. Roehrs TA, Randall S, Harris E, Maan R, Roth T (2011) Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study. Sleep 34:207–212

    PubMed  PubMed Central  Google Scholar 

  10. Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA (2005) An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med 6:487–495

  11. Uchimura N, Kamijo A, Takase T (2012) Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind study. Ann Gen Psychiatry 11:15. doi:10.1186/1744-859X-11-15

    Article  PubMed  PubMed Central  Google Scholar 

  12. Walsh JK, Krystal AD, Amato DA, Rubens R, Caron J, Wessel TC, Schaefer K, Roach J, Wallenstein G, Roth T (2007) Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep 30:959–968

    PubMed  PubMed Central  Google Scholar 

2.7.5. Risiken und Nebenwirkungen der Insomniebehandlung

  1. Barker MJ, Greenwood KM, Jackson M, Crowe SF (2004) Persistence of cognitive effects after withdrawal from longterm benzodiazepine use: ameta-analysis. Arch Clin Neuropsychol 19:437–454

    Article  PubMed  Google Scholar 

  2. Dassanayake T, Micie P, Carter G, Jones A (2011) Effects of benzodiazepines, antidepressants, and opoids on driving. A systematic review and meta-analysis of epidemiological and experimental evidence. Drug Saf 34:125–156

    Article  CAS  PubMed  Google Scholar 

  3. Hajak G, Müller WE, Wittchen HU, Pittrow D, Kirch W (2003) Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98(10):1371–1378

    Article  CAS  PubMed  Google Scholar 

  4. Hallfors DD, Saxe L (1993) The dependence potential of short half-life benzodiazepines. Am J Public Health 83:1300–1304

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hoffmann F, Pfannkuche M, Glaeske G (2008) Hochverbrauch von Zolpidem und Zopiclon. Nervenarzt 79:67–72

    Article  CAS  PubMed  Google Scholar 

  6. Hoffmann F, Scharffetter W, Glaeske G (2009) Verbrauch von Zolpidem und Zo-piclon auf Privatrezepten zwischen 1993 und 2007. Nervenarzt 80:578–583

    Article  CAS  PubMed  Google Scholar 

  7. Hoffmann F (2013) Benefits and risks of benzodiazepines and Z‑drugs: comparison of perceptions of GPs and community pharmacists in Germany. Ger Med Sci 11:1–7

    Google Scholar 

  8. Joya FL, Kripke DF, Loving RT, Dawson A, Kline LE (2009) Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem. J Clin Sleep Med 5:377–383

    PubMed  PubMed Central  Google Scholar 

  9. Kapil V, Green JL, Le Lait C, Wood M, Dargan PI (2014) Misuse of benzodiazepines and Z‑drugs in the UK. Br J Psychiatry 205:407–408

    Article  CAS  PubMed  Google Scholar 

  10. Kraus L, Pabst A (2010) Epidemiologischer Suchtsurvey. Repräsentativerhebung zum Gebrauch und Missbrauch psychoaktiver Substanzen bei Erwachsenen in Deutschland. Sucht 56:309–384

    Article  Google Scholar 

  11. Kripke DF, Simons RN, Garfinkel L, Hammond EC (1979) Short and long sleep and sleeping pills. Is increased mortality associated? Arch Gen Psychiatry 36:103–116

    Article  CAS  PubMed  Google Scholar 

  12. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR (2002) Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59:131–136

    Article  PubMed  Google Scholar 

  13. Kripke DF (2009) Do hypnotics cause death and cancer? The burden of proof. Sleep Med 10:275–276

    Article  PubMed  Google Scholar 

  14. Kripke DF (2011) Is insomnia associated with mortality? Sleep 34:557–558

    Google Scholar 

  15. Kripke DF (2013) Surprising view of insomnia and sleeping pills. Sleep 36:1127–1128

    PubMed  PubMed Central  Google Scholar 

  16. Kyle SD, Morgan K, Spiegelhalder K, Espie CA (2011) No pain, no gain: An exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia. Sleep Med 12:735–747

    Article  PubMed  Google Scholar 

  17. Kyle SD, Miller CB, Rogers Z, Siriwardena N, MacMahon KM (2014) Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: Implications for the clinical management of insomnia disorder. Sleep 37:229–237

    PubMed  PubMed Central  Google Scholar 

  18. Palmaro A, Dupouy J, Lapeyre-Mestre M (2015) Benzodiazepines and risk of death: results from two large cohort studies in France and UK. Eur Neuropsychopharmacol 25:1566–1577

    Article  CAS  PubMed  Google Scholar 

  19. Rapoport MJ, Lanctot KL, Streiner DL, Bedard M, Vingilis E, Murray B, Schaffer A, Shulman KL, Herrmann N (2009) Benzodiazepine use and driving: a meta-analysis. J Clin Psychiatry 70:663–673

    Article  CAS  PubMed  Google Scholar 

  20. Soldatos CR, Dikeos DG, Whitehead A (1999) Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies. Int Clin Psychopharmacol 14:287–303

    Article  CAS  PubMed  Google Scholar 

  21. Stranks EK, Crowe SF (2014) The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis. J Clin Exp Neuropsychol 36:691–700

    Article  PubMed  Google Scholar 

  22. Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH (2016) Association between zolpidem and suicide: a nationwide population-based case-control study. Mayo Clin Proc 91(3):308–315. doi:10.1016/j.mayocp.2015.10.022

    Article  CAS  PubMed  Google Scholar 

  23. Uhlenhuth EH, Balter MB, Ban TA, Yang K (1999) Benzodiazepine dependence and withdrawal: myths and management. J Clin Psychopharmacol 19(Suppl 2):23S–29S

    Article  CAS  PubMed  Google Scholar 

  24. Verster JC, Veldhuizen DS, Patat A, Olivier B, Volkerts ER (2006) Hypnotics and riving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test. Curr Drug Saf 1:63–71

    Article  CAS  PubMed  Google Scholar 

3. Empfehlungen

  1. Clinical Guidelines Committee of the American College of Physicians (2016) Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. doi:10.7326/M15-2175

    Google Scholar 

  2. Moher et al (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the quorom statement. Lancet 27:1890–1900

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Riemann.

Caption Electronic Supplementary Material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Riemann, D., Baum, E., Cohrs, S. et al. S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen. Somnologie 21, 2–44 (2017). https://doi.org/10.1007/s11818-016-0097-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11818-016-0097-x

Navigation